J 2022

Oral Candidiasis in Non‐Severe COVID‐19 Patients: Call for Antibiotic Stewardship

RIAD, Abanoub, Akram GAD, Barbora HOCKOVA and Miloslav KLUGAR

Basic information

Original name

Oral Candidiasis in Non‐Severe COVID‐19 Patients: Call for Antibiotic Stewardship

Authors

RIAD, Abanoub (818 Egypt, guarantor, belonging to the institution), Akram GAD (818 Egypt), Barbora HOCKOVA (703 Slovakia) and Miloslav KLUGAR (203 Czech Republic, belonging to the institution)

Edition

Oral surgery, United Kingdom, John Wiley & Sons, 2022, 1752-2471

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30208 Dentistry, oral surgery and medicine

Country of publisher

United States of America

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

RIV identification code

RIV/00216224:14110/22:00124854

Organization unit

Faculty of Medicine

DOI

Keywords in English

Oral Candidiasis; COVID‐19; Antibiotic Stewardship

Tags

Tags

International impact, Reviewed
Změněno: 3/4/2023 08:35, Mgr. Tereza Miškechová

Abstract

V originále

Bacterial/fungal coinfection is a suggested etiological theory for the COVID‐19 related oral manifestations that may trigger overprescribing of broad‐spectrum antibiotics for COVID‐19 patients, especially for the ones who experience a longer course of the infection. Rigorous reporting of the clinical scenarios of fungal complications such as oropharyngeal candidiasis (OPC) which could cause life‐threatening candidemia may help in understanding the ongoing pandemic and the potential role of dentists in frontline teams.Therefore, we aim to describe a non‐severe COVID‐19 case with oral candidiasis according to the CARE guidelines.